Our Mandate Is Simple...
To help and educate people so that they can regain
their health and achieve their fitness goals 7 minutes at a time..
Tuesday, July 5, 2016
FDA Approves Insys Therapeutics' 2nd Cannabis-Based Drug
On June 21, Todd Hagopian recommended Insys Therapeutics (INSY). Since then, the stock has gained nearly 20%. After a stock runs like this, many investors are tempted to sell. However, in situations like this, I've found it valuable to know which side of the trade the people with superior track records are on before making any trading decisions.